Giant Cell Glioblastoma
📧 Sign up to get email alerts when something new happens for Giant Cell Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas [Phase 1]
Phase 1 clinical trial update exploring vorinostat with temozolomide for malignant gliomas in adults, with active-not-recruiting status acro…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma [Phase 1]
Phase 1 dose-escalation trial of re-irradiation in good-prognosis recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) [Phase 1]
A Phase I pilot study evaluating S-Gboxin in combination with standard glioblastoma therapy; the trial assessing anti-glioblastoma effects i…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating NovoTTF-100A (tumor treating fields) combined with bevacizumab in recurrent glioblastoma has completed with results…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 2]
This Phase 2 trial evaluating bevacizumab with temozolomide in older patients with newly diagnosed glioblastoma or gliosarcoma has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating a Protein Phosphatase 2A inhibitor in recurrent glioblastoma and related gliomas completed, with results posted in …
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: DC Migration Study for Newly-Diagnosed GBM [Phase 2]
Phase 2 clinical trial update on dendritic cell migration for newly diagnosed glioblastoma; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating gefitinib with radiation therapy for glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating bevacizumab with or without radiation therapy in adults with recurrent glioblastoma has completed with results post…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating MRI and PET/FMISO imaging to assess tumor hypoxia in patients with newly diagnosed glioblastoma multiforme…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating aminolevulinic acid (5-ALA) for fluorescence-guided visualization of glioblastoma tumors during surgical resection …
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing plerixafor after radiation therapy and temozolomide in newly diagnosed high-grade glioma has completed wi…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma [Phase 2]
Phase 2 trial update for dovitinib in adults with recurrent or progressive glioblastoma. The study is completed, with results posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating erlotinib in adults with recurrent malignant glioma or recurrent/progressive meningioma; the study is co…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating gossypol for progressive or recurrent glioblastoma multiforme; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma [Phase 2]
Phase 2 trial of bendamustine hydrochloride in adults with recurrent or progressive anaplastic glioma has completed and results have been po…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas [Phase 1, Phase 2]
Results from a Phase I/II trial of BMS-247550 for recurrent high-grade gliomas have been posted, evaluating adults with anaplastic astrocyto…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: 3T MRI Biomarkers of Glioma Treatment Response [EARLY_Phase 1]
An early-phase 1 trial evaluating 3T MRI biomarkers for glioma treatment response, sponsored by Vanderbilt-Ingram Cancer Center, has been te…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma [Phase 1, Phase 2]
Clinical trial update for tandutinib in recurrent or progressive glioblastoma (Phase 1/2) reports completion with results posted in 2017. Th…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Pazopanib in Treating Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 trial update of pazopanib for recurrent glioblastoma; results have been posted following study completion.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma [Phase 1]
Phase 1 clinical trial evaluating a vaccine therapy in combination with sargramostim (GM-CSF) for malignant glioma, including several glioma…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors [Phase 2]
Phase 2 trial evaluating bevacizumab with or without trebananib for recurrent brain tumors has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors [Phase 1]
Phase 1 clinical trial evaluating aminolevulinic acid during surgery for malignant brain tumors; the study was terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: FR901228 in Treating Patients With Recurrent High-Grade Gliomas [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated FR901228 in adults with recurrent high-grade gliomas; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery [Phase 1]
This clinical trial update reports on a Phase 1 study of the oncolytic herpes simplex virus HSV-1716 in children with refractory or recurren…